The UK’s FTSE 100 declined on Thursday as investors assessed renewed tensions in the Middle East, while pharmaceutical heavyweight AstraZeneca weighed heavily on the benchmark after reporting disappointing results from a late-stage clinical trial. The blue-chip FTSE 100 index fell 0.6% to 10,417.63 points by 10:45 GMT. In contrast, the domestically focused FTSE 250 index
PepsiCo beat Wall Street expectations for second-quarter revenue and profit on Thursday, but investors focused on the company’s warning that inflationary pressures continue to weigh on consumer spending in North America, sending its shares slightly lower in premarket trading. The snacks and beverages giant reaffirmed its full-year outlook, as it continues to benefit from resilient
Micron Technology shares surged 6% in premarket trading on Thursday after the memory-chip maker announced plans to invest up to $3 billion to strengthen the US semiconductor supply chain. The bullish analyst commentary and improving sentiment toward AI-related memory demand further supported the stock. Micron announces $3 billion US supply chain investment Micron Technology said
US stocks opened higher on Thursday as gains in semiconductor shares helped offset renewed geopolitical concerns after fresh exchanges of attacks between the United States and Iran threatened to prolong the conflict and keep investors on edge. The Dow Jones Industrial Average fell 28 points, or 0.05%, while the S&P 500 gained 0.11%. Nasdaq Composite
Broadcom stock price rose by 5% on Wednesday after extending its relationship with Apple. AVGO rose to $395, a 10% increase from its lowest level this month. It remains in a local bear market after falling by 20% from its highest point this year. So, will it rebound and retest its all-time high? Broadcom expands
Salesforce Inc. (CRM) shares fell 2.5% on Thursday after KeyBanc downgraded the software company, citing concerns that its Agentforce artificial intelligence platform may take longer than expected to become a meaningful growth driver. The downgrade came despite Salesforce’s strong position in enterprise software and follows the company’s better-than-expected fiscal first-quarter results reported in late May.
The Schwab US Dividend Equity ETF (SCHD) has moved sideways in the past few days. It has remained inside the key support and resistance levels of $31.60 and $32.90 since May. Despite the consolidation, SCHD is having a strong year, with inflows rising by over $13 billion and its assets nearing the $100 billion mark.
Wall Street’s rally is facing a fresh Middle East test before the opening bell. US stock futures slid on Wednesday after President Donald Trump said the Iran peace memorandum was “over”, sending oil prices higher and putting renewed pressure on technology shares. Nasdaq 100 futures touched a four-week low as investors moved away from risk,
OpenAI will publicly launch its most capable artificial intelligence model, GPT-5.6, on Thursday after delaying the release last month at the request of the US government, as concerns grow over the potential misuse of advanced AI systems for national security purposes. The delay came amid heightened scrutiny of frontier AI models by US authorities, who
The ongoing artificial intelligence (AI) infrastructure boom has sparked an unprecedented memory supercycle, lifting chipmakers to historic heights. While Micron and SanDisk have captured massive headlines in recent months with exceptional triple- and quadruple-digit returns, a more dominant powerhouse may actually be a better pick to play the memory market upside. South Korean semiconductor giant